Etiology and treatment of pneumonia

被引:64
作者
McCracken, GH [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75235 USA
关键词
pneumonia; etiology; treatment; Streptococcus pneumoniae; Chlamydia pneumoniae; Mycoplasma pneumoniae; virus;
D O I
10.1097/00006454-200004000-00032
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background, Lower respiratory tract infections are a common cause of morbidity among children. Among these infections pneumonia is the most serious illness and can be difficult to diagnose. The etiology of pneumonia is still partly unknown, primarily because of difficulty in obtaining adequate samples and lack of reliable diagnostic methods. Etiology of pneumonia, Streptococcus pneumoniae is recognized as an important cause of pediatric pneumonia regardless of age in both the inpatient and outpatient setting. In developed countries S, pneumoniae probably accounts for 25 to 30% of cases of pediatric community-acquired pneumonia, Viruses (mostly respiratory syncytial virus) are responsible for similar to 20% of cases, and Chlamydia pneumoniae and Mycoplasma pneumoniae occur commonly in older children. Future challenges. Despite the effectiveness of antimicrobial therapy, the emergence of resistant bacterial pathogens has resulted in increased interest in developing more effective vaccines. If conjugate pneumococcal vaccines prove effective at eradicating carriage of pneumococci in the nasopharynx, immunization may be an important tool against the spread of pneumococcal disease. Future challenges include implementation of effective intervention strategies, production of simple diagnostic tools and development of effective vaccines.
引用
收藏
页码:373 / 377
页数:5
相关论文
共 22 条
[1]   EPIDEMIOLOGY OF LOWER RESPIRATORY-TRACT INFECTIONS [J].
BARIFFI, F ;
SANDUZZI, A ;
PONTICIELLO, A .
JOURNAL OF CHEMOTHERAPY, 1995, 7 (04) :263-276
[2]   Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[3]   MYCOPLASMA-PNEUMONIAE AND CHLAMYDIA-PNEUMONIAE IN PEDIATRIC COMMUNITY-ACQUIRED PNEUMONIA - COMPARATIVE EFFICACY AND SAFETY OF CLARITHROMYCIN VS ERYTHROMYCIN ETHYLSUCCINATE [J].
BLOCK, S ;
HEDRICK, J ;
HAMMERSCHLAG, MR ;
CASSELL, GH ;
CRAFT, JC .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (06) :471-477
[4]   Pneumococcal diversity: Considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA) [J].
Briles, DE ;
Tart, RC ;
Swiatlo, E ;
Dillard, JP ;
Smith, P ;
Benton, KA ;
Ralph, BA ;
Brooks-Walter, A ;
Crain, MJ ;
Hollingshead, SK ;
McDaniel, LS .
CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (04) :645-+
[5]  
BULLA A, 1978, B WORLD HEALTH ORGAN, V56, P481
[6]   COMPARISON OF THE RESPONSE TO ANTIMICROBIAL THERAPY OF PENICILLIN-RESISTANT AND PENICILLIN-SUSCEPTIBLE PNEUMOCOCCAL DISEASE [J].
FRIEDLAND, IR .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (10) :885-890
[7]  
Geddes AM, 1997, J CHEMOTHERAPY, V9, P5
[8]   Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children [J].
Harris, JAS ;
Kolokathis, A ;
Campbell, M ;
Cassell, GH ;
Hammerschlag, MR .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (10) :865-871
[9]   Etiology of childhood pneumonia:: serologic results of a prospective, population-based study [J].
Heiskanen-Kosma, T ;
Korppi, M ;
Jokinen, C ;
Kurki, S ;
Heiskanen, L ;
Juvonen, H ;
Kallinen, S ;
Stén, H ;
Tarkiainen, A ;
Rönnberg, PR ;
Kleemola, M ;
Mäkelä, H ;
Leinonen, M .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (11) :986-991
[10]  
ISAACS D, 1989, PEDIATR INFECT DIS J, V8, P143